A pilot study of freeze drying of poly(epsilon-caprolactone) nanocapsules stabilized by poly(vinyl alcohol): Formulation and process optimization

被引:154
作者
Abdelwahed, W [1 ]
Degobert, G [1 ]
Fessi, H [1 ]
机构
[1] Univ Lyon 1, LAGEP, CNRS, UMR 5007,CPE Lyon,ISPB, F-69622 Villeurbanne, France
关键词
emulsification-diffusion technique; nanocapsules; freeze drying; collapse; annealing; environmental scanning electron microscope;
D O I
10.1016/j.ijpharm.2005.10.003
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
A common limitation of using polymeric nanoparticles in aqueous suspension is due to their poor chemical and physical stability when conserved for a long time. Therefore, freeze drying of these colloidal systems is an alternative method to achieve long-term stability. Nanocapsules have thin and fragile shell structure, which may not resist to the stress of such process. The aim of this study is to investigate the formulation and process parameters in order to ensure the stability of polycaprolactone nanocapsules (PCL NC) by freeze drying. In this paper, we studied the freeze drying of PCL NC prepared by the emulsion-diffusion method and stabilized by poly(vinyl alcohol) (PVA). Different parameters have been tested throughout the freeze-thawing study including PVA and PCL concentration, cooling rate, cryoprotectant concentrations, nature of encapsulated oil and NC purification. On the other hand, nanocapsules have been freeze dried both before and after purification. Freeze dried purified PCL NC were characterized by particle size measurement, collapse temperature, T-g(') determination, scanning electron microscope observation, environmental scanning electron microscope imaging and residual humidity quantification. Finally, the effect of annealing on the NC stability and the sublimation rate has been well explored. The results suggest that PCL NC could be freeze dried without a cryoprotectant if the concentration of PVA stabilizer is sufficient (5%), while for the purified NC the addition of 5% of cryoprotectant seems to be necessary to ensure the stability of NC. The type of cryoprotectants had practically negligible effects on the size and the rehydration of freeze dried nanocapsules. The annealing process could accelerate the sublimation with the conservation of nanocapsules size. (c) 2005 Published by Elsevier B.V.
引用
收藏
页码:178 / 188
页数:11
相关论文
共 39 条
[1]   IN-VITRO EXTENDED-RELEASE PROPERTIES OF DRUG-LOADED POLY(DL-LACTIC ACID) NANOPARTICLES PRODUCED BY A SALTING-OUT PROCEDURE [J].
ALLEMANN, E ;
LEROUX, JC ;
GURNY, R ;
DOELKER, E .
PHARMACEUTICAL RESEARCH, 1993, 10 (12) :1732-1737
[2]   MODES OF INTERACTION OF CRYOPROTECTANTS WITH MEMBRANE PHOSPHOLIPIDS DURING FREEZING [J].
ANCHORDOGUY, TJ ;
RUDOLPH, AS ;
CARPENTER, JF ;
CROWE, JH .
CRYOBIOLOGY, 1987, 24 (04) :324-331
[3]  
Auvillain M., 1989, S.T.P. pharma, V5, P738
[4]   DYNAMIC PROPERTIES OF POLY(DL-LACTIDE) AND POLYVINYL-ALCOHOL MONOLAYERS AT THE AIR-WATER AND DICHLOROMETHANE WATER INTERFACES [J].
BOURY, F ;
IVANOVA, T ;
PANAIOTOV, I ;
PROUST, JE ;
BOIS, A ;
RICHOU, J .
JOURNAL OF COLLOID AND INTERFACE SCIENCE, 1995, 169 (02) :380-392
[5]   Nanoparticles in cancer therapy and diagnosis [J].
Brigger, I ;
Dubernet, C ;
Couvreur, P .
ADVANCED DRUG DELIVERY REVIEWS, 2002, 54 (05) :631-651
[6]   Stability and freeze-drying of cyclosporine loaded poly(D,L lactide-glycolide) carriers [J].
Chacón, M ;
Molpeceres, J ;
Berges, L ;
Guzmán, M ;
Aberturas, MR .
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 1999, 8 (02) :99-107
[7]  
Choi M.J., 2002, P 13 INT DRY S, P752
[8]   IS VITRIFICATION SUFFICIENT TO PRESERVE LIPOSOMES DURING FREEZE-DRYING [J].
CROWE, JH ;
LESLIE, SB ;
CROWE, LM .
CRYOBIOLOGY, 1994, 31 (04) :355-366
[9]   PREVENTION OF FUSION AND LEAKAGE IN FREEZE-DRIED LIPOSOMES BY CARBOHYDRATES [J].
CROWE, LM ;
WOMERSLEY, C ;
CROWE, JH ;
REID, D ;
APPEL, L ;
RUDOLPH, A .
BIOCHIMICA ET BIOPHYSICA ACTA, 1986, 861 (01) :131-140
[10]   Formulation and lyoprotection of poly(lactic acid-co-ethylene oxide) nanoparticles:: Influence on physical stability and in vitro cell uptake [J].
De Jaeghere, F ;
Allémann, E ;
Leroux, JC ;
Stevels, W ;
Feijen, J ;
Doelker, E ;
Gurny, R .
PHARMACEUTICAL RESEARCH, 1999, 16 (06) :859-866